Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Atorvastatin Enhances the Antitumor Activity of Tamoxifen in B16f10 Mouse Melanoma Cell Lines Publisher



Malek M1 ; Ghasemi M1 ; Vaseghi G2 ; Ghasemi A1 ; Esfahani HN3 ; Dana N3 ; Javanmard SH3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Physiology and Pharmacology (Iran) Published:2021


Abstract

Introduction: Tamoxifen has been used in the treatment of metastatic malignant melanoma more common with other agents in the combined therapy. Up-regulated activity of the meva-lonate pathway has been shown in a range of different cancers. Atorvastatin is the most com-monly used statin approved for cholesterol reduction by inhibiting the mevalonate pathway and has been shown to inhibit tumor growth. In the present study, we used atorvastatin and tamoxifen combination therapy on B16f10 mouse melanoma cell lines to study whether ator-vastatin could increase the sensitivity of melanoma cells to the chemotherapeutic agent such as tamoxifen. Methods: The cell line was treated with different concentrations of tamoxifen and/or ator-vastatin for 24 and 48h and the effects of treatment on p53 and RhoA were investigated using quantitative RT-PCR. Results: The combination of atorvastatin and tamoxifen resulted in a potentiation antitumor effect via up-regulation of p53 and down-regulation of RhoA expression against melanoma tumors in vitro. Furthermore, we demonstrated the combination of atorvastatin with tamoxifen could reduce tamoxifen dose to minimize possible detrimental side effects in melanoma. Conclusion: Our results suggested that atorvastatin as a combined therapy with tamoxifen may provide a new approach for improving the efficacy and treating against melanoma cancer but needs further exploration in clinical trials. © 2021, Iranian Society of Physiology and Pharmacology. All rights reserved.
Other Related Docs
11. The Role of Dietary Polyphenols in Alternating Dna Methylation in Cancer, Critical Reviews in Food Science and Nutrition (2023)
22. Curcumin: A New Candidate for Melanoma Therapy?, International Journal of Cancer (2016)
30. Inhibitory Effect of Genistein on Plc/Prf5 Hepatocellular Carcinoma Cell Line, International Journal of Preventive Medicine (2015)
31. The Tangled Web of Dyslipidemia and Cancer: Is There Any Association?, Journal of Research in Medical Sciences (2022)